Management of antirheumatic therapy around surgeries other than TKA and THA
There are limited data regarding perioperative use of DMARDs for surgeries other than elective TKAs and THAs, and recommendations are predominately based on expert opinion. For surgeries that involve opening the abdomen or chest, a reasonable approach is to stop csDMARDs and tsDMARDs 1 week prior to surgery, if possible, and resume 1 week after surgery in the absence of wound healing complications or infection. For bDMARDs, if possible the surgery should occur at the end of the dosing cycle and resume once there are signs of good wound healing, no evidence of infection, and all sutures/staples are removed (typically ∼14 days after surgery).
